Form SD iRhythm Holdings, Inc.
Tweet
Share
E-mailUNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
SPECIALIZED DISCLOSURE REPORT
iRhythm Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 001-37918 | 41-3421287 | ||||||||||||
(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
699 8th Street, Suite 600
San Francisco, California 94103
(Address of principal executive offices) (Zip code)
Daniel Wilson
Chief Financial Officer
(415) 632-5700
(Name and telephone number, including area code, of the person to contact in connection with this report)
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which this information in this form applies:
[X] Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1, 2025 to December 31, 2025
Item 1.01. Conflict Minerals Disclosure and Report.
Conflict Minerals Disclosure
A copy of the Conflict Minerals Report of iRhythm Holdings Inc. (“iRhythm”) for the reporting period January 1, 2025 to December 31, 2025 is filed as Exhibit 1.01 to this specialized disclosure report on Form SD and is also available at iRhythm’s website at https://investors.irhythmtech.com/financials/sec-filings.
Item 1.02. Exhibit.
iRhythm has filed, as an exhibit to this Form SD, a Conflict Minerals Report as required by Item 1.01 of this Form.
Item 2.01. Exhibits.
The following exhibit is filed as part of this report on Form SD:
| Exhibit Number | Description of Document | ||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
IRHYTHM TECHNOLOGIES, INC. | ||||||||||||||
Date: May 14, 2026 | By: | /s/ Daniel Wilson | ||||||||||||
Name: | Daniel Wilson | |||||||||||||
Title: | Chief Financial Officer | |||||||||||||
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FORE Awards New Grants to Strengthen Community-Based Responses to the Opioid and Overdose Crisis
- Perspire Sauna Studio Brings Back Summer Ritual Challenge to Inspire Consistent Wellness Rituals
- InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Lucid-MS Toward Phase 2 Trials for Multiple Sclerosis
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
